Literature DB >> 17531412

Effects of penetration enhancers on in vitro permeability of meloxicam gels.

R Jantharaprapap1, G Stagni.   

Abstract

Meloxicam (MLX) was formulated as a 0.3% hydroxypropylcellulose (Klucel) gel. The effect of four different combinations of co-solvents (ethanol, glycol-PEG-400, propylene glycol, and water) on MLX permeability was determined in vitro throughout isopropyl myristate (IPM)-saturated cellulose membranes. The gel consisting of 2.5% Klucel, propylene glycol, ethanol, and water (1:1:1) showed superior permeability properties and it was selected as the base-gel to investigate the effect of three levels of the penetration enhancers: dimethylsulfoxide (1, 5, and 10% DMSO), tween20 (1, 2, and 5% TW20), oleic acid (0.4, 1, and 5% OA), and menthol (1, 2.5, and 5% MT). In vitro permeability was determined throughout IPM-saturated cellulose membranes and human cadaver skin. DMSO and TW20 did not improve permeability of MLX compared to the control gel at any of the levels tested. Menthol produced a statistically significant (P<0.001), dose proportional increase in MLX flux with a peak at 5% (2.43+/-0.47 microg/cm2/h). Conversely, addition of OA peaked at 1% but decreased at the higher level (5%). There was no significant difference between the MLX amount recovered in stratum corneum and dermis across the different formulations tested. These findings show that the 0.3% MLX gel formulation containing 5% menthol can possibly deliver therapeutically relevant doses of MLX.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17531412     DOI: 10.1016/j.ijpharm.2007.04.011

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  13 in total

1.  Optimization of hydrogels for transdermal delivery of lisinopril by Box-Behnken statistical design.

Authors:  Ramesh Gannu; Vamshi Vishnu Yamsani; Shravan Kumar Yamsani; Chinna Reddy Palem; Madhusudan Rao Yamsani
Journal:  AAPS PharmSciTech       Date:  2009-04-28       Impact factor: 3.246

2.  Ion-pair formation combined with a penetration enhancer as a dual strategy to improve the transdermal delivery of meloxicam.

Authors:  Qikun Jiang; Jin Wang; Panqin Ma; Cuiru Liu; Mengchi Sun; Yinghua Sun; Zhonggui He
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

3.  Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers.

Authors:  Sureewan Duangjit; Praneet Opanasopit; Theerasak Rojanarata; Tanasait Ngawhirunpat
Journal:  AAPS PharmSciTech       Date:  2012-12-14       Impact factor: 3.246

4.  Effect of Different Carriers on in vitro Permeation of Meloxicam through Rat Skin.

Authors:  M A Saleem; Sumanji Bala; A Aeajaz
Journal:  Indian J Pharm Sci       Date:  2010-11       Impact factor: 0.975

5.  Characterization and In Vitro Skin Permeation of Meloxicam-Loaded Liposomes versus Transfersomes.

Authors:  Sureewan Duangjit; Praneet Opanasopit; Theerasak Rojanarata; Tanasait Ngawhirunpat
Journal:  J Drug Deliv       Date:  2010-11-07

6.  Status of surfactants as penetration enhancers in transdermal drug delivery.

Authors:  Iti Som; Kashish Bhatia; Mohd Yasir
Journal:  J Pharm Bioallied Sci       Date:  2012-01

7.  Meloxicam transdermal delivery: effect of eutectic point on the rate and extent of skin permeation.

Authors:  Soliman Mohammadi-Samani; Gholamhossein Yousefi; Farhad Mohammadi; Fatemeh Ahmadi
Journal:  Iran J Basic Med Sci       Date:  2014-02       Impact factor: 2.699

8.  Evaluation of skin permeation and analgesic activity effects of carbopol lornoxicam topical gels containing penetration enhancer.

Authors:  Saleh A Al-Suwayeh; Ehab I Taha; Fahad M Al-Qahtani; Mahrous O Ahmed; Mohamed M Badran
Journal:  ScientificWorldJournal       Date:  2014-06-19

9.  Effect of chemical enhancers in transdermal permeation of alfuzosin hydrochloride.

Authors:  D Prasanthi; P K Lakshmi
Journal:  ISRN Pharm       Date:  2012-12-20

10.  Effect of mechanical properties on the release of meloxicam from poloxamer gel bases.

Authors:  O Inal; E Alğin Yapar
Journal:  Indian J Pharm Sci       Date:  2013-11       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.